Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-4.4%/yr
vs -24.1%/yr prior
5Y CAGR
+1.4%/yr
Recent deceleration
Acceleration
+19.7pp
Accelerating
Percentile
P42
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.97M | -1.0% |
| 2024 | $22.20M | -28.6% |
| 2023 | $31.10M | +23.7% |
| 2022 | $25.13M | +6.4% |
| 2021 | $23.62M | +15.0% |
| 2020 | $20.53M | -26.2% |
| 2019 | $27.83M | -63.2% |
| 2018 | $75.65M | +128.5% |
| 2017 | $33.11M | +119.4% |
| 2016 | $15.09M | - |